Periodontal diseases and non-alcoholic fatty liver disease
Kh. N. Kerimov,
S. D. Arutyunov,
E. S. Malova,
V. G. Morozov,
Y. S. Degtyareva,
Y. N. Kharakh,
I. P. Balmasova,
V. N. Tsarev https://doi.org/10.33925/1683-3759-2022-27-1-4-12
Abstract
Relevance. Periodontal diseases, being an extremely common, do not only cause tooth loss and significantly affect the patients’ quality of life, but are also a risk factor for many systemic diseases and may subsequently aggravate their course. Non-alcoholic fatty liver disease (NAFLD) is one of the relatively understudied pathologies associated with periodontal diseases.
Materials and methods. A non-interventional study analytically reviewed Russian and international scientific publications, which presented the results of independent clinical and laboratory studies on the topic from 2011 to 2021.
Results. Scientific literature data evidence that NAFLD manifests by impaired lipid metabolism in liver cells, linked with mechanisms regulated by the liver nuclear receptors (LXR), and leads to such life-threatening conditions as liver cirrhosis and hepatocellular carcinoma. The information on the role of periodontal pathogens in NAFLD development has been accumulated by now. The example of such principal periodontal pathogen as Porphyromonas gingivalis experimentally demonstrated that it can integrate into the intestinal microbiome, migrate through the bloodstream to the liver, survive in hepatocytes and influence the nuclear receptors of these cells affecting the lipid metabolism and contributing to NAFLD development.
Conclusion. A detailed study of the link between periodontal disease and non-alcoholic fatty liver disease may contribute to the development of new effective strategies for the diagnosis and treatment of these pathological conditions.
About the Authors
Kh. N. Kerimov
Dental Clinic „Doctor Kerimov, LLC”
Russian Federation
Russian Federation
Khasan N. Kerimov, DMD, Doctor-in-Chief
Samara
S. D. Arutyunov
A.I. Yevdokimov Moscow State University of Medicine and Dentistry
Russian Federation
Russian Federation
Sergey D. Arutyunov, DMD, PhD, DSc, Professor, Head of the Department of Introduction to Dental Diseases
Moscow
E. S. Malova
Medical Company „Hepatologist, LLC”
Russian Federation
Russian Federation
Elena S. Malova, MD, PhD, DSc, Associate Professor, Deputy Director
Samara
V. G. Morozov
Medical Company „Hepatologist, LLC”
Russian Federation
Russian Federation
Vyacheslav G. Morozov, MD, PhD, DSc, Professor, Director
Samara
Y. S. Degtyareva
Medical Company „Hepatologist, LLC”
Russian Federation
Russian Federation
Yulia S. Degtyareva, MD
Samara
Y. N. Kharakh
A.I. Yevdokimov Moscow State University of Medicine and Dentistry
Russian Federation
Russian Federation
Yaser N. Kharakh, DMD, PhD, Associate Professor, Department of Introduction to Dental Diseases
Moscow
I. P. Balmasova
A.I. Yevdokimov Moscow State University of Medicine and Dentistry; Peoples’ Friendship University of Russia
Russian Federation
Russian Federation
Irina P. Balmasova, MD, PhD, DSc, Professor, Head of the Laboratory for the Study of Pathogenesis and Methods of Treatment of Infectious Diseases, Medical-Dental Research Institute
Moscow
V. N. Tsarev
A.I. Yevdokimov Moscow State University of Medicine and Dentistry
Russian Federation
Russian Federation
Viktor N. Tsarev, MD, PhD, DSc, Professor, Head of the Department of Microbiology, Virology, Immunology, Head of the Medical and Dental Research Institute
Moscow
References
1. Hajishengallis G. Immune evasion strategies of Porphyromonas gingivalis. Journal of Oral Biosciences. 2011;(3):233-240. doi: 10.2330/joralbiosci.53.233
2. Rajakaruna GA, Negi M, Uchida K, Sekine M, Furukawa A, Ito T, et al. Localization and density of Porphyromonas gingivalis and Tannerella forsythia in gingival and subgingival granulation tissues affected by chronic or aggressive periodontitis. Scientific Reports. 2018;(1):9507-9519. doi: 10.1038/s41598-018-27766-7
3. Balmasova IP, Tsarev VN, Yanushevich OO, Maev IV, Mkrtumyan AM, Arutyunov SD. Microecology of periodontal disease. The relationship between local and systemic effects. Moscow: Prakticheskaya meditsina, 2021. 264 p. (In Russ.). Available from: https://www.elibrary.ru/item.asp?id=46993123
4. Nikolayeva EN, Tsarev VN, Ippolitov EV. Periodontopathogenic bacterias as indicators of risk of occurrence and development of periodontitis (part 2). Stomatologiya dlya vsekh. 2011;(4):4–7. (In Russ.). Available from: https://www.elibrary.ru/item.asp?id=17279850&
5. Tsarev VN. Microbiology, virology, immunology. Moscow: GEOTAR-Media, 2013. 34–45 p (In Russ.).
6. Hegde R, Awan KH. Effects of periodontal disease on systemic health. Disease-A-Month. 2019;(6):185-192. doi: 10.1016/j.disamonth.2018.09.011
7. Tonetti MS, Jepsen S, Jin L, Otomo-Corgel J. Impact of the global burden of periodontal diseases on health, nutrition and wellbeing of mankind: A call for global action. Journal of clinical periodontology. 2017;(5):456-462. doi: 10.1111/jcpe.12732
8. Bui FQ, Almeida-da-Silva CLC, Huynh B, Trinh A, Liu J, Woodward J, et al. Association between periodontal pathogens and systemic disease. Biomedical Journal. 2019;(1):27-35. doi: 10.1016/j.bj.2018.12.001
9. Arutunov SD, Mayev IV, Romanenko NV, Surmayev EV. Features of a condition of periodontal tissues at the patients with a peptic ulcer of a duodenal intestine, associated with helicobacter pylori. Parodontologiia. 2005;(3):30-33. (In Russ.). Available from: https://www.elibrary.ru/item.asp?id=9483519
10. Arutyunov SD, Vertkin AL, Zayratyants OV, Pleskanovskaya NV, Naumov AV, Pshikhacheva MB. Clinical and morphological relationships of bone mineral density loss in periodontal diseases against the background of somatic pathology. Institut stomatologii. 2008;(2):88- 91. (In Russ.). Available from: https://www.elibrary.ru/item.asp?id=15275831
11. Suvan J, D'Aiuto F, Moles DR, Petrie A, Donos N. Association between overweight/obesity and periodontitis in adults. A systematic review. Obesity Reviews. 2011;(5):e381-404. doi: 10.1111/j.1467-789X.2010.00808.x
12. Nakahara T, Hyogo H, Ono A, Nagaoki Y, Kawaoka T, Miki D, et al. Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease. Journal of Gastroenterology. 2018;(2):269-280. doi: 10.1007/s00535-017-1368-4
13. Shin HS. Association between periodontal status and non-alcoholic fatty liver disease in a Korean adult population: A nationwide cross-sectional study. Journal of Periodontology. 2020;(4):524-532. doi: 10.1002/JPER.19-0291
14. Woodhouse CA, Patel VC, Singanayagam A, Shawcross DL. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease. Alimentary Pharmacology & Therapeutics. 2018;(2):192-202. doi: 10.1111/apt.14397
15. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;(1):124-131. doi: 10.1053/j.gastro.2010.09.038
16. Balmer ML, Slack E, de Gottardi A, Lawson MA, Hapfelmeier S, Miele L, et al. The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota. Science Translational Medicine. 2014;(237):237ra66. doi: 10.1126/scitranslmed.3008618
17. Alakhali MS, Al-Maweri SA, Al-Shamiri HM, AlHaddad K, Halboub E. The potential association between periodontitis and non-alcoholic fatty liver disease: a systematic review. Clinical Oral Investigations. 2018;(9):2965-2974. doi: 10.1007/s00784-018-2726-1
18. Han P, Sun D, Yang J. Interaction between periodontitis and liver diseases. Biomedical Reports. 2016;(3):267-276. doi: 10.3892/br.2016.718
19. Weintraub JA, Mitnik GL, Dye BA. Oral diseases associated with nonalcoholic fatty liver disease in the United States. Journal of Dental Research. 2019;(11):1219-1226. doi: 10.1177/0022034519866442
20. Yoneda M, Naka S, Nakano K, Wada K, Endo H, Mawatari H, et al. Involvement of a periodontal pathogen, porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease. BMC Gastroenterology. 2012;(12):16. doi: 10.1186/1471-230X-12-16
21. Akinkugbe AA, Avery CL, Barritt AS, Cole SR, Lerch M, Mayerle J, et al. Do genetic markers of inflammation modify the relationship between periodontitis and nonalcoholic fatty liver disease? Findings from the SHIP study. Journal of Dental Research. 2017;(12):1392-1399. doi: 10.1177/0022034517720924
22. Alazawi W, Bernabe E, Tai D, Janicki T, Kemos P, Samsuddin S, et al. Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease. PLoS One. 2017;(12):e0185902. doi: 10.1371/journal.pone.0185902
23. Kuroe K, Furuta M, Takeuchi K, Takeshita T, Suma S, Shinagawa T, et al. Association between periodontitis and fibrotic progression of non-alcoholic fatty liver among Japanese adults. Journal of Clinical Periodontology. 2021;(3):368-377. doi: 10.1111/jcpe.13415
24. Ma J, Hwang SJ, Pedley A, Massaro JM, Hoffmann U, Chung RT, et al. Bi-directional analysis between fatty liver and cardiovascular disease risk factors. Journal of Hepatology. 2017;(2):390-397. doi: 10.1016/j.jhep.2016.09.022
25. Wijarnpreecha K, Panjawatanan P, Cheungpasitporn W, Lukens FJ, Harnois DM, Pungpapong S, Ungprasert P. The Association between Periodontitis and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Journal of Gastrointestinal and Liver Diseases. 2020; (2):211-217. doi: 10.15403/jgld-841
26. Li L, Michel R, Cohen J, Decarlo A, Kozarov E. Intracellular survival and vascular cell-to-cell transmission of Porphyromonas gingivalis. BMC Microbiology. 2008;(8):26-36. doi: 10.1186/1471-2180-8-26
27. Huang N, Shaik-Dasthagirisaheb YB, La Valley MP, Gibson 3rd FC. Liver X receptors contribute to periodontal pathogen-elicited inflammation and oral bone loss. Molecular Oral Microbiology. 2015;(6):438-450. doi: 10.1111/omi.12103
28. Zhang N, Lv H, Shi BH, Hou X, Xu X. Inhibition of IL-6 and IL-8 production in LPS-stimulated human gingival fibroblasts by glycyrrhizin via activating LXRα. Microbial Pathogenesis. 2017;110:135-139. doi: 10.1016/j.micpath.2017.06.021
29. Russell DW. Oxysterol biosynthetic enzymes. Biochimica et Biophysica Acta. 2000;(1-3):126-135. doi: 10.1016/S1388-1981(00)00142-6
30. Hong C, Tontonoz P. Liver X receptors in lipid metabolism: opportunities for drug discovery. Nature Reviews Drug Discovery. 2014;(6):433-444. doi: 10.1038/nrd4280
31. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes & Development. 1995;(9):1033-1045. doi: 10.1101/gad.9.9.1033
32. Uzel NG, Teles FR, Teles RP, Song XQ, Torresyap G, Socransky SS, Haffajee AD. Microbial shifts during dental biofilm re-development in the absence of oral hygiene in periodontal health and disease. Journal of Clinical Periodontology. 2011;(7):612-620. doi: 10.1111/j.1600-051X.2011.01730.x
33. Ahn SB, Jang K, Jun DW, Lee BH, Shin KJ. Expression of liver X receptor correlates with intrahepatic inflammation and fibrosis in patients with nonalcoholic fatty liver disease. Digestive Diseases and Sciences. 2014;(12):2975-2982. doi: 10.1007/s10620-014-3289-x
34. Cave MC, Clair HB, Hardesty JE, Falkner KC, Feng W, Clark BJ, et al. Nuclear receptors and nonalcoholic fatty liver disease. Biochimica et Biophysica Acta. 2016;(9):1083-1099. doi: 10.1016/j.bbagrm.2016.03.002
35. Ito A, Hong C, Rong X, Zhu X, Tarling EJ, Hedde PN, et al. LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling. eLife. 2015;4:e08009. doi: 10.7554/eLife.08009
36. Arimatsu K, Yamada H, Miyazawa H, Minagawa T, Nakajima M, Ryder MI, et al. Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota. Scientific Reports. 2014;4:4828-4836. doi: 10.1038/srep04828
37. Nakajima M, Arimatsu K, Kato T, Matsuda Y, Minagawa T, Takahashi N, et al. Oral administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of enterobacteria to the liver. PLoS One. 2015;(7):e0134234. doi: 10.1371/journal.pone.0134234
38. Okumura T. Role of lipid droplet proteins in liver steatosis. Journal of Physiology and Biochemistry. 2011;(4):629-636. doi: 10.1007/s13105-011-0110-6
39. Nagaya T, Tanaka N, Kimura T, Kitabatake H, Fujimori N, Komatsu M, et al. Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy. BBA Clinical. 2015;3:168-174. doi: 10.1016/j.bbacli.2015.02.001
40. Ding LY, Liang LZ, Zhao YX, Yang YN, Liu F, Ding QR, et al. Porphyromonas gingivalis-derived lipopolysaccharide causes excessive hepatic lipid accumulation via activating NF-κB and JNK signaling pathways. Oral Diseases. 2019;(7):1789-1797. doi: 10.1111/odi.13153
41. Zaitsu Y, Iwatake M, Sato K, Tsukuba T. Lipid droplets affect elimination of Porphyromonasgingivalis in HepG2 cells by altering the autophagy-lysosome system. Microbes and Infection. 2016;(9):565-571. doi: 10.1016/j.micinf.2016.05.004
42. Sasaki N, Katagiri S, Komazaki R, Watanabe K, Maekawa S, Shiba T, et al. Endotoxemia by Porphyromonas gingivalis injection aggravates non-alcoholic fatty liver disease, Disrupts glucose/lipid metabolism, and alters gut microbiota in mice. Frontiers in Microbiology. 2018;9:2470. doi: 10.3389/fmicb.2018.02470
43. Komazaki R, Katagiri S, Takahashi H, Maekawa S, Shiba T, Takeuchi Y, et al. Periodontal pathogenic bacteria, Aggregatibacter actinomycetemcomitans affect non-alcoholic fatty liver disease by altering gut microbiota and glucose metabolism. Scientific Reports. 2017;(1):13950. doi: 10.1038/s41598-017-14260-9
44. Sun HL, Wu YR, Song FF, Gan J, Huang LY, Zhang L, et al. Role of PCSK9 in the development of mouse periodontitis before and after treatment: A double-¬edged sword. The Journal of Infectious Diseases. 2018;(4):667-680. doi: 10.1093/infdis/jix574
45. Kuraji R, Sekino S, Kapila Y, Numabe Y. Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral-liver axis. Periodontology 2000. 2021;(1):204-240. doi: 10.1111/prd.12387
Review
For citations:
Kerimov KN, Arutyunov SD, Malova ES, Morozov VG, Degtyareva YS, Kharakh YN, Balmasova IP, Tsarev VN. Periodontal diseases and non-alcoholic fatty liver disease. Parodontologiya. 2022;27(1):4-12. (In Russ.) https://doi.org/10.33925/1683-3759-2022-27-1-4-12
Views:
452
Email this article 